A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD

Area of Science:

• Pulmonary Medicine
• Cardiology
• Public Health

Background:

• Chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVDs) share common risk factors and pathophysiological mechanisms.
• CVDs are highly prevalent in patients with COPD, and exacerbations significantly increase the short- and long-term risk of cardiovascular events.
• Current clinical management strategies for preventing cardiovascular events post-exacerbation in COPD patients require optimization.

Purpose of the Study:

• To emphasize the critical link between COPD exacerbations and subsequent cardiovascular (CV) events.
• To highlight the underestimation of CV risk in COPD patients by conventional risk assessment tools.
• To advocate for comprehensive cardiovascular risk assessment and management in all COPD patients, especially during exacerbations.

Main Methods:

• Review of existing literature on the interplay between COPD and CVD.
• Analysis of the impact of COPD exacerbations on cardiovascular event risk.
• Evaluation of current cardiovascular risk assessment tools in the context of COPD.

Main Results:

• COPD exacerbations lead to a sustained increase in the risk of cardiovascular events.
• Standard cardiovascular risk prediction tools often underestimate CV risk in COPD patients.
• Cardiovascular events can occur in COPD patients without prior CVD diagnosis.

Conclusions:

• Preventing COPD exacerbations is a key strategy to reduce cardiovascular morbidity and mortality.
• All COPD patients require thorough cardiovascular risk assessment, including during exacerbations.
• Integrated management of COPD and CVD, guided by established protocols, is vital for improving patient survival.